Montgomery Hospice & Prince George's Hospice

NeuroCytonix, Inc. is a pioneering medical company challenging the traditional approaches to neurological diseases by offering innovative solutions for brain repair and the treatment of incurable conditions. Led by Dr. J. Roberto Trujillo, a renowned expert in clinical and basic neuroscience research, the company's transformational technology stimulates brain regeneration through a non-invasive and safe protocol using instantaneous magnetic fields and targeted radiofrequency waves. With a well-established clinical center in Monterrey, Mexico, NeuroCytonix has gained recognition from the Mexican regulatory authority COFEPRIS for its successful clinical trial and approved protocol for cerebral palsy. The company's groundbreaking neural tissue engineering technology aims to restore the structure of the nervous system, offering hope to patients suffering from conditions such as stroke, traumatic brain injuries, and cerebral palsy.Generated from the website